In addition, metabolic H2S has been reported to improve insulin resistance in mice with non-alcoholic fatty liver disease via the AKT signaling pathway (73), suggesting that an overabundance of Deltaproteobacteria and their descendants colonizing the human gut may disrupt the balance of the local microbiota and become pathogenic. This evidence concerns the gene AKT1 and metabolic dysfunction-associated steatotic liver disease.